Cargando…
Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
Necrostatin-1 (Nec-1) is a RIP1-targeted inhibitor of necroptosis, a form of programmed cell death discovered and investigated in recent years. There are already many studies demonstrating the essential role of necroptosis in various diseases, including inflammatory diseases, cardiovascular diseases...
Autores principales: | Cao, Liyuan, Mu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962892/ https://www.ncbi.nlm.nih.gov/pubmed/33181319 http://dx.doi.org/10.1016/j.phrs.2020.105297 |
Ejemplares similares
-
Necroptosis, necrostatins and tissue injury
por: Smith, Christopher CT, et al.
Publicado: (2011) -
Necrostatin-1 treatment inhibits osteocyte necroptosis and trabecular deterioration in ovariectomized rats
por: Cui, Hongwang, et al.
Publicado: (2016) -
Loading necrostatin-1 composite bone cement inhibits necroptosis of bone tissue in rabbit
por: Ji, Xiang, et al.
Publicado: (2019) -
Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice
por: Liu, Chang, et al.
Publicado: (2022) -
Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis
por: Chen, Fuxiang, et al.
Publicado: (2017)